Hyaluronan binding protein (HABP) is a ubiquitously present glycoprotein having specific affinity towards hyaluronic acid (HA). HA, also known as Hyaluronan, is a naturally occurring glycosaminoglycan that is functionally important for the maintenance of a highly hydrated extracellular matrix in tissues, which is involved in cell adhesion and ...

2024年12月25日 · HABP4 (Hyaluronan Binding Protein 4) is a Protein Coding gene. Among its related pathways is Response to elevated platelet cytosolic Ca2+. An important paralog of this gene is SERBP1.

2009年12月30日 · Hyaluronic acid binding protein (HABP) 2 regulates vascular permeability in acute lung injury models in vivo. A through C, Male B6129N2 mice (aged 8–10 weeks) were treated intravenously with 10 mg/kg of in vivo stable scramble siRNA (control) or …

Introduction: Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) continue to be common infections causing significant morbidity and mortality worldwide. The timely initiation of empiric antimicrobial therapy is essential.

Hyaluronan (HA) is an ubiquitous extracellular matrix polymer that plays many roles in health and disease. The ability to view the spatial and temporal expression of HA in tissues and on/in cells has provided researchers with insights into the tremendously diverse biological processes in which HA is involved.

透明质酸与聚集蛋白聚糖球状结构域1特异性结合，该蛋白通常被称为透明质酸结合蛋白（HABP），但是，尚未对HABP识别的透明质酸碳水化合物结构进行详细研究。 本研究的目的是研究透明质酸与HABP结合的重要结构。 我们制备了透明质酸和软骨素的杂化寡糖，具有或不具有修饰的还原性或非还原性末端，可作为通过竞争性ELISA法确定透明质酸与HABP结合的优选结构的工具。 非还原末端结构至关重要，尤其是葡萄糖醛酸（GlcUA）和 N 透明质酸单位的β-乙 …

2023年2月10日 · 天津科技大学罗学刚课题组选择了首个被FDA批准用于商业化产品的细胞穿透肽Pep-1，同时结合一种HA透皮吸收肽HaBP，以促进HA的透皮吸收。 研究表明：经过比例优化后，Pep-1/HaBP复合物不仅可有效提升HA在表皮细胞及离体模拟皮肤模型中的跨膜转运能力，而且 …

透明质酸结合蛋白（habp） 透明质酸 (HA) 广泛存在于细胞外间隙，是由D-葡萄糖醛酸及N-乙酰葡糖胺二糖单位重复组成的线状多糖，分子量10～1000KD；透明质酸与聚集蛋白聚糖球状结构域1特异性结合，称为透明质酸结合蛋白 (HABP)。

透明质酸结合蛋白（HABP），中和抗原. 别名：Hyaluronic acid binding Protein (HABP),Neutralizing antigen; HABP; 编码：EDD0411A; 级别： 简介：储存条件： 存储在-20℃。

FDA today approved a new indication for the previously FDA-approved drug, Zerbaxa (ceftolozane and tazobactam) for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated...